Levofloxacin Hemihydrate
Brand Formulations & Prices
122 brands sorted by unit price
Exolev
Leoflox
Levolon
Orlev
Levomet
Lexazen
Teriflox
Lexlo
Tivanik
Levox
Evo
Lequin
Levoxin
Lin
Avelox
Evocin
Maxlev
Neolev
Isovox
Levocin
Levostin
Lexlo
Evoloxin
Evonex
3-F
Coslev
Levin
Levolex
Levolon
Levonix
Lexazen
Locin
Prevo
Levora
Lerof
Levocos
Urilev
Asilee
Bacnil
Beloxin
Corbic
Flovo
Laxod
Lecocin
Leevotin
Leevotin
Lefex
Leosil
Letab
Levocare
Levodon
Levoflox
Levofloxacin
Levolo
Levomax
Levonal
Levonce
Levosafe
Lexa
Lezon
Lotor
Lovicin
Loxin
Nivoloc
Olcin
Quilev
Resquin
Trilon
Xelevo
Xenolev
Orlev
Levobac
Leoflox
Lethiquin
Levonor
Lin
Livacin
Orgalev
Radibac
Levoking
Lifcin
Tivanik
Orlev
Quixin
Genolev
Leflox
Levosina
Evo
Exolev
Leo
Levoday
Levoseem
Levox
Neovox
Toplevo
Benfloxin
Levoxin
Ovel
Trevox
Evo
Levoflox
Levomax
Levoxin
Levonor
Levoking
Levox
Leflox
Levosina
Levo
Evo
Lifcin
Levox
Levoking
Levoxin
G-Levofloxacin
Evo
Levobac
Levoxin
Urilev
Trevox
Levox
Orlev
📖 Official Clinical Monograph
DGDA Approved Prescribing Guidelines3-F is indicated for the treatment of mild, moderate and severe infections caused by susceptible strains of the designated micro-organisms in the condition listed below:
Acute maxillary sinusitis due to Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis.
... Read more
3-F is indicated for the treatment of mild, moderate and severe infections caused by susceptible strains of the designated micro-organisms in the condition listed below:
Acute maxillary sinusitis due to Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis.
Acute bacterial exacerbation of chronic bronchitis due to Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis.
Community-acquired pneumonia due to Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Chlamydia pneumoniae, Legionella pneumophila, or Mycoplasma pneumoniae.
Uncomplicated & complicated urinary tract infections due to Escherichia coli, Klebsiella pneumoniae, or Staphylococcus saprophyticus.
Acute pyelonephritis caused by Escherichia coli.
Uncomplicated & complicated skin and soft tissue infections including abscesses, cellulitis, furuncles, impetigo, pyoderma, wound infections, due to Staphylococcus aureus, Streptococcus pyogenes, Proteus mirabilis or Enterococcus faecalis.
Enteric infections caused by Enterobacter sp., Escherichia coli, Campylobacter sp., Vibrio cholerae, Shigella sp., Salmonella sp.
Levofloxacin is contraindicated in patients with a history of hypersensitivity to levofloxacin, quinolone antimicrobial agents, or any other components of this product.
3-F is generally well tolerated. However, a few side-effects can usually be seen. There is a risk of retinal detachment. Other side-effects include: nausea, vomiting, diarrhea, abdominal pain, flatulence and rare occurrence of phototoxicity (0.1%). Side-effects that may be seen very rarely include tremors, depression, anxiety, confusion etc.
The following measures should be taken during administration of 3-F:
3-F Injection should only be administered by slow intravenous infusion over a period of 60 or 90 minutes depending on the dosage.
While administrating 3-F, adequate amount of water should be taken to avoid concentrated form of urine.
Dose adjustment should be exercised during 3-F administration in presence of renal insufficiency.
Levofloxacin is a synthetic, broad-spectrum, third generation fluoroquinolone antibiotic. Chemically, Levofloxacin is a chiral fluorinated carboxyquinolone. Levofloxacin exerts antibacterial action by inhibiting bacterial topoisomerase IV and DNA gyrase, the enzymes required for DNA replication, transcription repair and recombination. It has in vitro activity against a wide range of gm-ve and gm+ve microorganisms.